Synchron, a brain-computer interface company, and Team Gleason, a foundation dedicated to improving the lives of people living with Amyotrophic Lateral Sclerosis (ALS), today announced an expanded partnership focused on raising awareness of Synchron’s BCI Community. The collaboration highlights a shared commitment to empowering people living with paralysis and accelerating the development of innovative solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250106917024/en/

The BCI Community is a place to bring people living with disabilities, care partners, and clinicians together to learn how BCI is being designed to provide autonomy to people with limited mobility and keep interested parties informed about upcoming trial opportunities. Team Gleason will play a key role in driving enrollment and engagement.

“We’re excited to expand our partnership with Team Gleason to amplify the reach of our BCI Community,” said Tom Oxley, M.D., CEO & Founder, Synchron. “By working together, we can ensure that more people have the opportunity to participate in shaping the future of neuroprosthetics and BCI technology.”

Team Gleason will support the BCI Community initiative by sharing information through newsletters, support groups, and social media channels. This outreach aims to inform community members and care partners about the importance of accelerating the development of life-changing solutions like Synchron’s brain-computer interface technology.

“The BCI Community initiative provides a unique opportunity for individuals living with ALS to directly shape the next generation of assistive technology," said Blair Casey, Executive Director of Team Gleason. "Through our ongoing collaboration with Synchron, we are ensuring that the voices of people living with neurological conditions remain at the forefront of innovation, driving the development of solutions that truly meet their needs.”

The Synchron BCI is implanted in the blood vessel on the surface of the motor cortex of the brain via the jugular vein, through a minimally invasive endovascular procedure. Once implanted, it is designed to detect and wirelessly transmit motor intent out of the brain, intended to restore the capability for severely paralyzed patients to control personal devices with hands-free point-and-click.

For more information about the Synchron BCI and our registry, visit https://synchronbci.com.

About the Synchron BCI Community

Synchron’s BCI community is designed to advance the development of its endovascular brain computer interface by gathering insights from individuals with paralysis or severe motor impairments. This initiative also allows an opportunity for individuals with paralysis to learn more about Synchron’s upcoming clinical trials. For more information, visit https://synchronbci.com.

About Team Gleason

Team Gleason Foundation was founded by former New Orleans Saints player, Steve Gleason, after his diagnosis with Amyotrophic Lateral Sclerosis (ALS) in 2011. Team Gleason’s mission is to improve life for people living with ALS by delivering innovative technology and equipment, as well as providing and empowering an improved life experience. For more information on how to help people living with ALS have the resources and the opportunities to not only continue living, but continue living productive, purposeful, and meaningful lives, please visit www.TeamGleason.org.

About Synchron

Synchron is a neurotechnology company developing an endovascular brain-computer interface (BCI) designed to restore functionality in people with severe paralysis. The clinical-stage company is developing a neuroprosthesis to restore motor signaling to control digital devices and autonomy for individuals with motor impairment. Synchron is headquartered in New York City. For more information, visit www.synchron.com. Follow us @synchroninc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250106917024/en/